Iranian Journal of Nuclear Medicine

Iranian Journal of Nuclear Medicine

The Iranian Journal of Nuclear Medicine (Iran J Nucl Med) is an open-access, peer-reviewed journal dedicated to the advancement of nuclear medicine and its related disciplines. In alignment with its mission to support the global scientific community, the journal does not charge any fees for manuscript submission, processing, or publication, thereby providing a cost-free platform for researchers worldwide.

Established in 1993 by the Research Center for Nuclear Medicine at Tehran University of Medical Sciences, the journal is published in collaboration with the Iranian Society of Nuclear Medicine. Since its inception, Iran J Nucl Med has served as a reputable forum for the dissemination of high-quality research in both basic and clinical nuclear medicine sciences.

The journal covers a broad spectrum of topics, including but not limited to molecular imaging, functional and metabolic assessment of diseases, radionuclide therapy, radiopharmacy, radiochemistry, radiobiology, dosimetry, nuclear medicine instrumentation, and computational applications in nuclear medicine. It welcomes original research articles, systematic reviews, meta-analyses, narrative reviews, mini-reviews, short communications, editorials, case reports, and letters to the editor—particularly those addressing emerging global trends, regional advancements, and critical issues in the field.

Initially published in Persian (1993–1994), the journal adopted a bilingual format (Persian and English) from 1994 to 2007, and has been published exclusively in English since early 2008. Iran J Nucl Med maintains an international editorial board and accepts submissions from researchers around the world, aiming to foster scientific exchange and professional education among physicians, technologists, and specialists involved in nuclear medicine.

 

 Iran J Nucl Med is a member of the Committee on Publication Ethics (COPE).

   ********************************************************************

 SCImago Journal & Country Rank
Impact Factor (2024): 0.3
 
 
 
Current Issue: Volume 34, Supplement 1, September 2026, Pages 1-67 

Publication Information

Publisher

Founding Editor
Editor-in-Chief
Language Editor
Executive Assistant

Frequency
Semiannual
Print ISSN
Online ISSN

Keywords Cloud

  • SPECT
  • Nuclear medicine
  • SPECT/CT
  • Myocardial perfusion imaging
  • PET/CT
  • Biodistribution
  • prostate cancer
  • Lymphoscintigraphy
  • PET
  • Breast cancer
  • Scintigraphy
  • Bone scintigraphy
  • Bone scan
  • Gated SPECT
  • Thyroid cancer
  • Monte Carlo
  • quality control
  • [18F]FDG
  • Metastasis
  • Myocardial perfusion scan
  • Myocardial perfusion
  • Dosimetry
  • [18F]FDG PET/CT
  • 99mTc-MIBI
  • Radioiodine
  • Bone metastasis
  • Radiopharmaceutical
  • Radiolabeling
  • Differentiated thyroid carcinoma
  • Attenuation correction
  • Technetium-99m
  • Differentiated thyroid cancer
  • Sentinel lymph node
  • coronary artery disease
  • Monte Carlo Simulation
  • 99mTc-MDP
  • Absorbed dose
  • Positron emission tomography
  • Covid-19
  • Sentinel node
  • [99mTc]Tc-MDP
  • Radiopharmaceuticals
  • Iran
  • Hyperthyroidism
  • I-131
  • False-positive
  • Tumor
  • Radionuclide imaging
  • Dipyridamole
  • Radioactive iodine
  • effective dose
  • Pulmonary embolism
  • Myocardial perfusion SPECT
  • Radiation protection
  • Renal scintigraphy
  • 99mTc
  • Parathyroid adenoma
  • Breast
  • In-111
  • Renography
  • Chitosan
  • Hyperparathyroidism
  • PET-CT
  • HYNIC
  • Infection
  • Tc-99m MDP
  • Radionuclide therapy
  • SPECT-CT
  • osteoporosis
  • Gamma camera
  • Copper-64
  • Skeletal scintigraphy
  • Therapy
  • [99mTc]Tc-DMSA
  • Delayed imaging
  • 177Lu
  • Ejection fraction
  • SUVmax
  • Osteomyelitis
  • Echocardiography
  • Radiosynovectomy
  • fdg
  • Bleomycin
  • Colorectal cancer
  • MRI
  • Soft tissue uptake
  • Cardiology
  • Iodine-131
  • Simulation
  • Kidney
  • Phase analysis
  • Cancer
  • Radioligand therapy
  • Multiple Myeloma
  • Sestamibi
  • [99mTc]Tc-EC
  • Primary hyperparathyroidism
  • Oncology
  • Hydronephrosis
  • Bombesin
  • Imaging
  • Optimization
  • [99mTc]Tc-PSMA
  • 99mTc-DMSA
  • Planar imaging
  • Neuroendocrine tumor
  • Image quality
  • Artificial intelligence
  • Sensitivity
  • 18F-FDG PET/CT
  • Radiochemical purity
  • Sub-diaphragmatic activity
  • Artifacts
  • Melanoma
  • Spatial resolution
  • Holmium-166
  • Fibrosarcoma
  • Google scholar
  • Sm-153
  • Lymphoma
  • Radiotherapy
  • Evidence based medicine
  • Pitfall
  • [99mTc]Tc-MIBI
  • Transient ischemic dilation
  • 153Sm-EDTMP
  • Gallium-67
  • Somatostatin
  • Thyroid gland
  • DTPA
  • Myocardial uptake
  • NCAT
  • myocardium
  • Artifact
  • DOTATOC
  • Ischemic heart disease
  • cyclotron
  • Malignancy
  • Hepatocellular Carcinoma
  • Brain Perfusion SPECT
  • Occupational exposure
  • Molecular imaging
  • Ga-67
  • Critical appraisal
  • Salivary gland scintigraphy
  • chemotherapy
  • Tc-99m antimony sulfide colloid
  • Nuclear medicine staff
  • Meckel’s scan
  • Brain SPECT
  • Radionuclides
  • MIBI
  • Radiolabeled peptide
  • Composite
  • Eidolon
  • Brain imaging
  • Lung perfusion scintigraphy
  • Gastrointestinal bleeding
  • Salivary Gland
  • Cardiac SPECT/CT
  • Lead
  • BPAMD
  • attenuation
  • Re-injection
  • SCImago journal rank indicator
  • Differential diagnosis
  • Bone pain
  • Time-of-Flight
  • Pain palliation
  • Hybrid imaging
  • Radiology
  • Gamma probe
  • Parathyroid
  • Thyroidectomy
  • Differential renal function
  • Cardiac events
  • Epiphora
  • Blue dye
  • Staging
  • TENIS syndrome
  • mCRPC
  • Stability
  • Extraosseous uptake
  • Image reconstruction
  • Renal cell carcinoma
  • Radionuclide
  • Machine learning
  • Indium-111
  • menopause
  • Breast uptake
  • Left ventricular volume
  • Meckel’s diverticulum
  • Meningioma
  • Quality of Life
  • 99mTc-MIBI scintigraphy
  • Tc-99m sestamibi
  • Ultrasonography
  • MIRD
  • Pain
  • Dacryocystorhinostomy